Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

Konstantin N. Zabegalov, Tatiana O. Kolesnikova, Sergey L. Khatsko, Andrey D. Volgin, Oleg A. Yakovlev, Tamara G. Amstislavskaya, Polina A. Alekseeva, Darya A. Meshalkina, Ashton J. Friend, Wandong Bao, Konstantin A. Demin, Raul R. Gainetdinov, Allan V. Kalueff*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science